Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Analysts

Key Points

• Health Catalyst, Inc. (NASDAQ:HCAT) has received a consensus rating of "Hold" from eleven brokerages, with eight analysts recommending holding the stock and three issuing buy recommendations.
• The average 1-year price target for Health Catalyst among analysts is $4.73, with varying recent adjustments from research firms, including Evercore ISI and BTIG Research.
• Shares of Health Catalyst were down 4.3%, currently trading at approximately $2.89, reflecting its market capitalization of $203.37 million.

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has earned a consensus recommendation of "Hold" from the eleven analysts that are currently covering the firm, Marketbeat.com reports. Eight analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $4.7273.

HCAT has been the topic of several recent analyst reports. Stifel Nicolaus reduced their price objective on shares of Health Catalyst from $5.50 to $4.50 and set a "hold" rating on the stock in a research note on Friday, August 8th. Canaccord Genuity Group reduced their price objective on shares of Health Catalyst from $9.00 to $5.00 and set a "buy" rating on the stock in a research note on Friday, August 29th. Piper Sandler downgraded shares of Health Catalyst from an "overweight" rating to a "neutral" rating and dropped their target price for the stock from $8.00 to $4.00 in a report on Wednesday, August 27th. Wells Fargo & Company lowered their price objective on shares of Health Catalyst from $10.00 to $6.00 and set an "overweight" rating on the stock in a report on Monday, August 11th. Finally, Evercore ISI lifted their price objective on shares of Health Catalyst from $3.00 to $4.00 and gave the company an "in-line" rating in a report on Thursday, August 28th.

Health Catalyst Price Performance

Shares of Health Catalyst stock traded down $0.01 during mid-day trading on Friday, reaching $2.94. 179,696 shares of the stock were exchanged, compared to its average volume of 724,078. The company has a market cap of $206.89 million, a price-to-earnings ratio of -1.96 and a beta of 1.53. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44. Health Catalyst has a fifty-two week low of $2.52 and a fifty-two week high of $9.24. The firm has a 50-day simple moving average of $3.39 and a 200 day simple moving average of $3.79.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Group One Trading LLC raised its stake in Health Catalyst by 107.6% in the fourth quarter. Group One Trading LLC now owns 4,360 shares of the company's stock valued at $31,000 after purchasing an additional 2,260 shares in the last quarter. Cresset Asset Management LLC acquired a new position in Health Catalyst during the second quarter worth about $39,000. Divergent Planning LLC acquired a new position in Health Catalyst during the second quarter worth about $45,000. Focus Partners Wealth acquired a new position in Health Catalyst during the first quarter worth about $46,000. Finally, XTX Topco Ltd acquired a new position in Health Catalyst during the first quarter worth about $54,000. Institutional investors and hedge funds own 85.00% of the company's stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.